Without warning, the Royal Pharmaceutical Society (RPS) held a meeting in June 2024 to decide whether the current RPS policy and position in relation to the open sale and supply of P medicines should be changed.
Many PDA members have expressed concerns about this unexpected development and that this issue is now being reconsidered by the RPS and others. The PDA’s position is that there are many good reasons for the P medicines category and the fact that these medicines are sold from a more controlled environment in the community pharmacy has been good for patients, pharmacists, and the healthcare system.
To ensure that members views are considered in this debate, the PDA is now consulting its members. PDA members, please complete the survey below by 2 August 2024.
Learn more
- P medicines for self-selection, are you concerned?
- PDA challenges RPS on its ‘open display of P medicines’ policy review
- P meds on self-selection. GPhC decision must be challenged
- Self-selection of P medicines – not in the public interest!
Not yet a PDA member?
If you have not yet joined the PDA, we encourage you to join today and ask your colleagues to do the same.
Membership is FREE to pharmacy students, trainee pharmacists and for the first three months of being newly qualified.
Read about our key member benefits here.